Madison Avenue Partners, LP Pliant Therapeutics, Inc. Transaction History
Madison Avenue Partners, LP
- $774 Million
- Q1 2025
A detailed history of Madison Avenue Partners, LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 1,675,043 shares of PLRX stock, worth $2.23 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,675,043Holding current value
$2.23 Million% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding PLRX
# of Institutions
153Shares Held
60.9MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$7.98 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$7.18 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$6.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$4.43 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.06 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $64.7M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...